Channel Therapeutics Corporation (CHRO)
NYSEAMERICAN: CHRO · Real-Time Price · USD
0.633
+0.003 (0.48%)
Dec 30, 2024, 4:00 PM EST - Market closed
Channel Therapeutics Market Cap
Channel Therapeutics has a market cap or net worth of $3.82 million as of December 30, 2024.
Market Cap
3.82M
Enterprise Value
4.85M
1-Year Change
n/a
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since the IPO on February 16, 2024, Channel Therapeutics's market cap has decreased from $33.50M to $3.82M, a decrease of -88.61%. That is a compound annual growth rate of -91.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 27, 2024 | 3.80M | -88.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 705.19B |
| UnitedHealth Group | 469.34B |
| Novo Nordisk | 393.39B |
| Johnson & Johnson | 349.23B |
| AbbVie | 314.57B |
| Merck & Co. | 252.20B |
| AstraZeneca | 204.17B |
| Thermo Fisher Scientific | 201.22B |